They expected approval by Chinas drug administration (forgot the name) to allow it to be sold as a medically approved substance. Was due in Dec 2019.
EHH have opened up 300 or so 'customer experience stores' across China and invested $1m into a high speed processing machine. They intend to sell into those stores.
Omni would receive royalties from sales.
Hoping something in the upcoming quarterly to confirm the above.
Honey is the money maker though - 21,000 units to be shipped in Jan 2020 to China.. at $14.50 a jar thats about $300,000 AUD.
(EDIT: Held. Hold.)
- Forums
- ASX - By Stock
- EVE
- Ann: Investor Presentation
Ann: Investor Presentation, page-20
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EVE (ASX) to my watchlist
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.274M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EVE (ASX) Chart |
Day chart unavailable